Trade

with

Coronado Biosciences Inc
(NASDAQ: CNDO)
AdChoices
1.79
-0.04
-2.19%
After Hours :
-
-
-

Open

1.80

Previous Close

1.83

Volume (Avg)

101.72k (199.12k)

Day's Range

1.79-1.94

52Wk Range

1.25-3.31

Market Cap.

79.32M

Dividend Rate ( Yield )

-

Beta

1.56

Shares Outstanding

44.31M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 0

    • Net Income

    • -37.16M

    • Market Cap.

    • 79.32M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.56

    • Forward P/E

    • -

    • Price/Sales

    • -

    • Price/Book Value

    • 1.10

    • Price/Cash flow

    • -2.57

      • EBITDA

      • -35.22M

      • Return on Capital %

      • -37.22

      • Return on Equity %

      • -49.14

      • Return on Assets %

      • -37.22

      • Book Value/Share

      • 1.63

      • Shares Outstanding

      • 44.31M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 1.70

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -0.83

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -

            • 82.75

            • Pre-Tax Margin

            • -

            • 39.38

            • Net Profit Margin

            • -

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.19

              • 0.76

              • Current Ratio

              • 22.25

              • 2.92

              • Quick Ratio

              • 22.14

              • 2.35

              • Interest Coverage

              • -13.51

              • 38.02

              • Leverage Ratio

              • 1.26

              • 2.21

              • Book Value/Share

              • 1.63

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -2.11

                • 243.90

                • P/E Ratio 5-Year High

                • -15.00

                • 634.30

                • P/E Ratio 5-Year Low

                • -1.48

                • 124.82

                • Price/Sales Ratio

                • -

                • 9.29

                • Price/Book Value

                • 1.10

                • 8.39

                • Price/Cash Flow Ratio

                • -2.57

                • 49.75

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -49.14

                        (-)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -37.22

                        (-)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -36.96

                        (-)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • -

                      • 1.48

                      • Asset Turnover

                      • -

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -35.78M
                      Operating Margin
                      -
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -2.57
                      Ownership

                      Institutional Ownership

                      20.80%

                      Top 10 Institutions

                      16.23%

                      Mutual Fund Ownership

                      4.64%

                      Float

                      69.43%

                      5% / Insider Ownership

                      20.64%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Total Stock Mkt Idx

                      •  

                        524,732

                      • 0.00

                      • 1.18

                      • Royce Micro-Cap Trust

                      •  

                        360,000

                      • 0.00

                      • 0.81

                      • Vanguard Extended Market Index Fund

                      •  

                        301,819

                      • 3.00

                      • 0.68

                      • Royce Value Trust

                      •  

                        170,000

                      • 0.00

                      • 0.38

                      • Advent-Claymore Enhanced Growth & Income

                      •  

                        145,000

                      • 0.00

                      • 0.33

                      • Vanguard Instl Total Stock Market Index

                      •  

                        139,507

                      • 0.00

                      • 0.31

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        94,005

                      • 0.00

                      • 0.21

                      • iShares Micro-Cap

                      •  

                        78,279

                      • 0.00

                      • 0.16

                      • Westcore Micro Cap Opportunity Fund

                      •  

                        63,943

                      • 0.00

                      • 0.14

                      • Global Trend Equity OP

                      •  

                        50,000

                      • 0.00

                      • 0.11

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Elliott Management Corp

                      •  

                        3,731,279

                      • 0.00%

                      • 8.42

                      • Vanguard Group, Inc.

                      •  

                        902,664

                      • -4.16%

                      • 2.04

                      • Royce & Associates, LLC

                      •  

                        530,000

                      • 0.00%

                      • 1.20

                      • Renaissance Technologies Corp

                      •  

                        523,900

                      • +33.51%

                      • 1.18

                      • Northern Trust Investments, N.A.

                      •  

                        283,436

                      • -13.33%

                      • 0.64

                      • Ancora Advisors LLC

                      •  

                        266,350

                      • +19.09%

                      • 0.60

                      • Goldman, Sachs & Co.

                      •  

                        232,202

                      • +84.07%

                      • 0.52

                      • Merrill Lynch & Co Inc

                      •  

                        209,837

                      • +92.86%

                      • 0.47

                      • Morgan Stanley & Co Inc

                      •  

                        186,185

                      • +637.31%

                      • 0.42

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Distressed

                      Style

                      Small Growth

                      Coronado Biosciences Inc was incorporated on June 28, 2006. It is a biopharmaceutical company focused on novel immunotherapy biologic agents for autoimmune diseases and cancer. Its two main product candidates in clinical development ...moreare: TSO and CNDO-109. TSO, or CNDO-201, is a biologic comprising Trichuris suis ova, the microscopic eggs of the porcine whipworm. TSO is a biologic product candidate for the treatment of autoimmune diseases. CNDO-109 is a lysate that is disrupted CTV-1 cells, cell membrane fragments, cell proteins and other cellular components that activates donor Natural Killer cells. CTV-1 is a leukemic cell line re-classified as a T-cell acute lymphocytic leukemia, or ALL. The Company faces competition from many different sources, including commercial pharmaceutical and biotechnolog...morey enterprises, academic institutions, government agencies, and private and public research institutions. Government authorities in the United States, at the federal, state and local level, and other countries regulate, among other things, the research, development, testing, manufacture, quality control, approval, labeling, packaging, storage, record-keeping, promotion, advertising, distribution, post-approval monitoring and reporting, marketing and export and import of products.lessless

                      Key People

                      Dr. Lindsay A. Rosenwald, M.D.

                      CEO/Chairman of the Board/Director/President

                      Dr. Eric K. Rowinsky,M.D.

                      Director/Vice Chairman of the Board

                      Dr. Lucy Lu, M.D.

                      CFO/Executive VP

                      Michael S. Weiss

                      Director/Executive VP, Divisional

                      Mr. David J. Barrett

                      Director

                      • Coronado Biosciences Inc

                      • 24 New England Executive Park

                      • Burlington, MA 01803

                      • USA.Map

                      • Phone: +1 781 652-4500

                      • Fax: +1 781 652-4545

                      • coronadobiosciences.com

                      Incorporated

                      2006

                      Employees

                      14

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: